Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Verity Pharmaceuticals
Verity Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Trelstar
Triptorelin
2000-06-15
2029
Prostatic neoplasms
Tlando
Testosterone undecanoate
2022-03-28
2026-2041
Breast neoplasms
,
Hypogonadism
,
Delayed puberty
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Nepidermin
precancerous conditions
,
non-small-cell lung carcinoma
,
lung neoplasms
,
breast neoplasms
,
head and neck neoplasms
,
triple negative breast neoplasms
,
esophageal neoplasms
,
ovarian neoplasms
,
erbb-1 genes
,
neoplasms
,
adenocarcinoma
,
mycoses
,
prostatic neoplasms
,
neoplasm metastasis
,
bipolar disorder
,
overactive urinary bladder
,
rheumatoid arthritis
,
arthritis
,
candidemia
,
invasive candidiasis
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
kidney transplantation
,
aspergillosis
,
invasive fungal infections
,
atrial fibrillation
,
atrial flutter
,
recurrence
,
coronary artery disease
,
kidney diseases
,
renal insufficiency
,
coronary disease
,
myocardial ischemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use